CochLear Shares Outstanding 2023-2024 | CHEOY
CochLear shares outstanding history from 2023 to 2024. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
- CochLear shares outstanding for the quarter ending June 30, 2024 were 0M, a 0% increase year-over-year.
- CochLear 2024 shares outstanding were 0.131B, a 0.27% decline from 2023.
- CochLear 2023 shares outstanding were 0.132B, a 0.19% increase from 2022.
- CochLear 2022 shares outstanding were 0.132B, a 0.06% increase from 2021.
| CochLear Annual Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2024 | 131 |
| 2023 | 132 |
| 2022 | 132 |
| 2021 | 131 |
| 2020 | 119 |
| 2019 | 115 |
| 2018 | 115 |
| 2017 | 115 |
| 2016 | 114 |
| CochLear Quarterly Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2024-06-30 | |
| 2023-12-31 | |
| 2023-06-30 | |
| 2022-06-30 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $11.426B | $1.488B |
| Cochlear Limited provides implantable hearing solutions principally in the Americas, Europe, the Middle East, Africa and the Asia Pacific. The company offers cochlear implants, including Nucleus 7 and Kanso sound processors; Carina middle-ear implants and accessories and Baha bone conduction implants. Cochlear Limited is based in Sydney, Australia. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $135.269B | 25.37 |
| Elevance Health (ELV) | United States | $85.392B | 11.02 |
| CVS Health (CVS) | United States | $79.000B | 9.82 |
| Cencora (COR) | United States | $56.052B | 19.50 |
| DiDi Global (DIDIY) | China | $22.921B | 34.79 |
| Natera (NTRA) | United States | $22.013B | 0.00 |
| BioMerieux (BMXMF) | France | $15.348B | 0.00 |
| Solventum (SOLV) | United States | $12.566B | 13.30 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.094B | 0.00 |
| Revvity (RVTY) | United States | $10.766B | 18.53 |
| ICON (ICLR) | Ireland | $10.566B | 9.82 |
| Viatris (VTRS) | United States | $10.082B | 3.46 |
| Doximity (DOCS) | United States | $9.641B | 44.90 |
| Avantor (AVTR) | United States | $8.879B | 12.90 |
| HealthEquity (HQY) | United States | $8.778B | 43.18 |
| Medpace Holdings (MEDP) | United States | $8.445B | 22.43 |
| Sonic Healthcare (SKHHY) | Australia | $8.256B | 0.00 |
| Charles River Laboratories (CRL) | United States | $6.692B | 13.11 |
| Amplifon S.p.A (AMFPF) | Italy | $4.966B | 27.18 |
| Bausch + Lomb (BLCO) | Canada | $4.050B | 23.88 |
| BrightSpring Health Services (BTSG) | United States | $4.042B | 37.42 |
| Sotera Health (SHC) | United States | $3.463B | 19.68 |
| Alignment Healthcare (ALHC) | United States | $2.978B | 0.00 |
| Surgery Partners (SGRY) | United States | $2.933B | 38.14 |
| Concentras Parent (CON) | United States | $2.751B | 15.90 |
| Organon (OGN) | United States | $2.379B | 2.53 |
| Ardent Health Partners (ARDT) | United States | $2.120B | 9.04 |
| GeneDx Holdings (WGS) | United States | $1.998B | 76.94 |
| Premier (PINC) | United States | $1.885B | 14.31 |
| Progyny (PGNY) | United States | $1.822B | 40.09 |
| PACS (PACS) | United States | $1.494B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.354B | 27.07 |
| Teladoc Health (TDOC) | United States | $1.223B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.179B | 8.97 |
| Establishment Labs Holdings (ESTA) | $1.038B | 0.00 | |
| Ryman Healthcare (RYHTY) | New Zealand | $1.011B | 0.00 |
| CareDx (CDNA) | United States | $0.978B | 15.27 |
| Agilon Health (AGL) | United States | $0.973B | 0.00 |
| Nutex Health (NUTX) | United States | $0.921B | 13.92 |
| AMN Healthcare Services Inc (AMN) | United States | $0.810B | 7.58 |
| QDM (QDMI) | Hong Kong, SAR China | $0.743B | 0.00 |
| Embecta (EMBC) | United States | $0.617B | 4.15 |
| InnovAge Holding (INNV) | United States | $0.547B | 0.00 |
| Enhabit (EHAB) | United States | $0.525B | 43.17 |
| LifeMD (LFMD) | United States | $0.521B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.479B | 10.78 |
| SBC Medicals (SBC) | United States | $0.466B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.465B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.395B | 0.00 |
| Oncology Institute (TOI) | United States | $0.278B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.220B | 0.00 |
| Beauty Health (SKIN) | United States | $0.208B | 0.00 |
| KindlyMD (KDLY) | United States | $0.150B | 0.00 |
| KindlyMD (NAKA) | United States | $0.146B | 0.00 |
| DocGo (DCGO) | United States | $0.139B | 22.67 |
| OncoCyte (OCX) | United States | $0.095B | 0.00 |
| So-Young (SY) | China | $0.090B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.065B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.062B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.057B | 0.00 |
| Biodesix (BDSX) | United States | $0.050B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.039B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.032B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.019B | 0.00 |
| ModivCare (MODV) | United States | $0.013B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.012B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.010B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.010B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.006B | 0.00 | |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |